Neurology: Volume 97, Number 3, July 20, 2021 Exam #1 - Reversible Cerebral Vasoconstriction Syndrome: Symptoms, Incidence, and Resource Utilization in a Population-Based US Cohort

About this course

  • Released: 07/20/2021
  • Expires: 07/20/2024

REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME: SYMPTOMS, INCIDENCE, AND RESOURCE UTILIZATION IN A POPULATION-BASED US COHORT

LEARNING OBJECTIVES:

Upon completion of the article by Magid-Bernstein et al, the participant should be able to:
  • Identify the most commonly seen concomitant neurologic diagnoses among patients with reversible cerebral vasoconstriction syndrome (RCVS) included in this study
  • Describe the most common reasons for an emergency department (ED) visit in the 90 days prior to hospitalization among patients with RCVS included in this study
  • State the proportion of patients hospitalized with RCVS who had at least subsequent ED visit following discharge from their index hospitalization in this study


CORE COMPETENCIES:

The article by Magid-Bernstein et al covers the following core competency:
  • Medical Knowledge

AUTHOR DISCLOSURES:

Refer to Information and Author section available in the Tool Bar for each article.

 

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

AMA CREDIT DESIGNATION STATEMENT

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURES

CME Journal Editors: James W.M. Owens, Jr., MD, PhD: Scientific Advisory Boards: Member of data safety monitoring board, RaSURE study, AADi Bioscience, Inc. Funding for travel or speaker honoraria: Honoraria, Program Director, AAN Annual Meeting. Editorial Boards: CME Editor, Neurology and Adam Kelly, MD: Editorial Boards: Neurology, CME editor, ongoing since January 2016. Other activities: Question writing for American Academy of Neurology activities, including Continuum. AAN staff members editing the test (K. Aman Ramm) have no disclosures.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

ACCME